Paradoxically, elevated PAI-1 expression is associated with increased tumor invasiveness and metastatic potential in malignancies such as osteosarcoma, head and neck squamous cell carcinoma, and breast cancer [49,71]. Here, SERPINE1 is linked to breast carcinoma.